Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonel Trebicka

Showing results (341-350 of 511) with videos related to

Pageof 52
Sort By:
Haematologica|February 16, 2015
Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosisElisabeth P C Plompen, Peter J M Valk, Isabel Chu, et al.
Scientific Reports|September 29, 2015
Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertensionFrank E Uschner, Ganesh Ranabhat, Steve S Choi, et al.
Gut|September 20, 2015
Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosisSabine Klein, Johanna Rick, Jennifer Lehmann, et al.
JHEP Reports : Innovation in Hepatology|November 11, 2024
Palmitoylcarnitine impairs immunity in decompensated cirrhosisIngrid Wei Zhang, María Belén Sánchez-Rodríguez, Cristina López-Vicario, et al.
Communications Biology|June 12, 2021
AGO2 localizes to cytokinetic protrusions in a p38-dependent manner and is needed for accurate cell divisionVasiliki I Pantazopoulou, Anastasios D Delis, Stella Georgiou, et al.
Alimentary Pharmacology & Therapeutics|July 10, 2019
Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90-day mortalityChristian Jansen, Devnandan Amor Chatterjee, Karen Louise Thomsen, et al.
Hepatology (Baltimore, Md.)|July 4, 2021
Proximal Splenic Artery Embolization to Treat Refractory Ascites in a Patient With CirrhosisCristian Caporali, Laura Turco, Francesco Prampolini, et al.
JHEP Reports : Innovation in Hepatology|March 22, 2022
Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPSMenghao Li, Kai Li, Shihao Tang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 15, 2012
Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in ratsSabine Klein, Jeremias Klösel, Robert Schierwagen, et al.
Plos Neglected Tropical Diseases|December 21, 2021
TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literatureTamara Nordmann, Stefan Schlabe, Torsten Feldt, et al.
Pageof 52

Showing results (341-350 of 511) with videos related to

Sort By:
Pageof 52
Haematologica|February 16, 2015
Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosisElisabeth P C Plompen, Peter J M Valk, Isabel Chu, et al.
Scientific Reports|September 29, 2015
Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertensionFrank E Uschner, Ganesh Ranabhat, Steve S Choi, et al.
Gut|September 20, 2015
Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosisSabine Klein, Johanna Rick, Jennifer Lehmann, et al.
JHEP Reports : Innovation in Hepatology|November 11, 2024
Palmitoylcarnitine impairs immunity in decompensated cirrhosisIngrid Wei Zhang, María Belén Sánchez-Rodríguez, Cristina López-Vicario, et al.
Communications Biology|June 12, 2021
AGO2 localizes to cytokinetic protrusions in a p38-dependent manner and is needed for accurate cell divisionVasiliki I Pantazopoulou, Anastasios D Delis, Stella Georgiou, et al.
Alimentary Pharmacology & Therapeutics|July 10, 2019
Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90-day mortalityChristian Jansen, Devnandan Amor Chatterjee, Karen Louise Thomsen, et al.
Hepatology (Baltimore, Md.)|July 4, 2021
Proximal Splenic Artery Embolization to Treat Refractory Ascites in a Patient With CirrhosisCristian Caporali, Laura Turco, Francesco Prampolini, et al.
JHEP Reports : Innovation in Hepatology|March 22, 2022
Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPSMenghao Li, Kai Li, Shihao Tang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 15, 2012
Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in ratsSabine Klein, Jeremias Klösel, Robert Schierwagen, et al.
Plos Neglected Tropical Diseases|December 21, 2021
TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literatureTamara Nordmann, Stefan Schlabe, Torsten Feldt, et al.
Pageof 52